{"id":62651,"date":"2026-02-16T16:06:00","date_gmt":"2026-02-16T15:06:00","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/"},"modified":"2026-02-16T16:06:00","modified_gmt":"2026-02-16T15:06:00","slug":"europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/","title":{"rendered":"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–#MRD<\/a>–A new survey-based Genomics Tracker<\/i> focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe\u2019s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a cross-market view of current priorities, barriers, and areas of momentum.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe Europe Oncology Genomics Tracker characterizes the current clinical use of genomic testing across a patient\u2019s treatment journey (e.g., genomic profiling, MRD \/ recurrence monitoring, treatment response monitoring) and tracks how use changes over time. Oncology respondents were asked about their use of genomic testing in routine clinical practice within the past three months, as well as their familiarity with various vendors in the ecosystem.<\/p>\n

\nThe survey was distributed randomly to oncologists practicing in the UK, France, Germany, Italy, or Spain. Respondents were selected to complete the survey if they were actively practicing medical oncologists or hematologist-oncologists and had seen at least 25 patients in the past three months. Respondents were not excluded from the survey if they were not currently using, or had not previously used, genomics for biomarker testing.<\/p>\n

\nDeciBio Partner and leading author of the tracker, Andrew Aijian, notes the value of integrating the EU tracker into a broader suite of genomics trackers, \u201cAdoption of precision medicine is growing steadily across Europe, though each market presents unique drivers and moderators. The country-specific healthcare frameworks and infrastructure in Europe require different strategies for precision oncology than what we see in the U.S. Having visibility into genomics testing practices in these regions is critical for any precision oncology stakeholder to identify opportunities and risks, and develop locally-optimized strategies.\u201d<\/p>\n

\nBased on recent clinician survey data, the tracker quantifies real-world adoption of testing for treatment selection, detailing tissue versus liquid biopsy use, panel size mix, provider awareness and perception, and the competitive dynamics shaping ordering behavior. It extends beyond profiling to capture emerging use of ctDNA for MRD, recurrence, and treatment response monitoring, highlighting utilization by care setting, confidence in clinical utility, vendor share shifts, pain points, and sales and marketing visibility. Together, these insights enable biopharma, diagnostics, and investors to benchmark performance, identify inflection points in adoption, and prioritize commercial and evidence-generation strategies grounded in current EU clinical practice.<\/p>\n

\nLearn more about DeciBio\u2019s Europe Oncology Genomics Tracker: https:\/\/www.decibio.com\/product\/europe-oncology-genomics-tracker<\/a><\/p>\n

\nWhile this tracker is inaugural for the European oncology market, it complements DeciBio\u2019s U.S. Oncology Genomics Tracker.<\/i> This tool is also distributed on a quarterly basis and similarly aims to characterize current clinical use of genomic testing across genomic profiling, MRD \/ recurrence monitoring, and treatment response monitoring, as well as track changes over time in the United States.<\/p>\n

\nLearn more about DeciBio\u2019s U.S Oncology Genomics Tracker: https:\/\/www.decibio.com\/product\/u-s-oncology-genomics-tracker<\/a><\/p>\n

\nAbout DeciBio:<\/p>\n

\nDeciBio Consulting (www.decibio.com<\/a>) is the leading strategy consulting, market intelligence, and SaaS firm dedicated to accelerating innovation in precision medicine.<\/p>\n

\nHeadquartered in Los Angeles, California, DeciBio serves a global base of clients and customers, ranging from startups to Fortune 500 healthcare corporations. DeciBio offers advisory services for growth planning, market and opportunity assessment, product and portfolio strategy, voice-of-customer feedback, technology assessment, and commercial due diligence.<\/p>\n

Contacts<\/b> <\/p>\n

\nHannah Glazier
\n
glazier@decibio.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–#MRD–A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe\u2019s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62651","6":"format-standard","7":"category-industry"},"yoast_head":"\nEurope Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–#MRD–A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe\u2019s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-16T15:06:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260216151238\/en\/2721324\/22\/Decibio-wordmark-black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC\",\"datePublished\":\"2026-02-16T15:06:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/\"},\"wordCount\":570,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260216151238\\\/en\\\/2721324\\\/22\\\/Decibio-wordmark-black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/\",\"name\":\"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260216151238\\\/en\\\/2721324\\\/22\\\/Decibio-wordmark-black.jpg\",\"datePublished\":\"2026-02-16T15:06:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260216151238\\\/en\\\/2721324\\\/22\\\/Decibio-wordmark-black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260216151238\\\/en\\\/2721324\\\/22\\\/Decibio-wordmark-black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/","og_locale":"en_US","og_type":"article","og_title":"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–#MRD–A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe\u2019s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/","og_site_name":"Pharma Trend","article_published_time":"2026-02-16T15:06:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260216151238\/en\/2721324\/22\/Decibio-wordmark-black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC","datePublished":"2026-02-16T15:06:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/"},"wordCount":570,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260216151238\/en\/2721324\/22\/Decibio-wordmark-black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/","url":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/","name":"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260216151238\/en\/2721324\/22\/Decibio-wordmark-black.jpg","datePublished":"2026-02-16T15:06:00+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260216151238\/en\/2721324\/22\/Decibio-wordmark-black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260216151238\/en\/2721324\/22\/Decibio-wordmark-black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/europe-oncology-genomics-tracker-captures-oncologist-perspectives-across-major-european-markets-data-report-by-decibio-consulting-llc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets \u2013 Data Report by DeciBio Consulting LLC"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62651"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62651\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}